Need help finding treatment? Speak with an advisor: (855) 420-1911 — Free & Confidential
Medically Reviewed by Dr. Sarah Mitchell

Medication-Assisted Treatment (MAT) Near You

Find MAT providers offering buprenorphine (Suboxone), methadone, and naltrexone (Vivitrol) across all 50 states.

8,920Facilities
50States
Free & Confidential

Find Treatment

Our advisors help you navigate insurance, find available beds, and connect with the right facility.

(855) 420-1911
or verify your insurance online

Your information is kept strictly confidential. By submitting, you agree to our privacy policy.

Understanding Medication-Assisted Treatment

Medication-assisted treatment combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders. For opioid use disorder specifically, MAT is considered the gold standard of care by every major medical organization including the WHO, AMA, ASAM, and NIH.

MAT is not "replacing one drug with another." These are evidence-based medications that normalize brain chemistry, block the euphoric effects of opioids, relieve physiological cravings, and stabilize body functions — allowing patients to engage in therapy and rebuild their lives.

MAT Medications Compared

Buprenorphine (Suboxone) is a partial opioid agonist available in daily sublingual films/tablets or monthly injections (Sublocade). It can be prescribed in office-based settings. Methadone is a full opioid agonist dispensed daily at federally licensed clinics. Naltrexone (Vivitrol) is an opioid antagonist available as a monthly injection, requiring full detox before initiation.

Access to MAT: Current Landscape

The elimination of the X-waiver in 2023 significantly expanded the number of providers who can prescribe buprenorphine, though access gaps remain — particularly in rural areas. Methadone remains restricted to federally licensed opioid treatment programs (OTPs). Our directory includes both office-based buprenorphine prescribers and OTPs.

Sources & References

  1. [1] NIDA. Medications to Treat Opioid Use Disorder. 2024.
  2. [2] SAMHSA. Medications for Opioid Use Disorder. TIP 63. 2021.
  3. [3] WHO. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. 2009.

MAT: Common Questions

The three FDA-approved MAT medications are: buprenorphine (brand: Suboxone, Sublocade) which reduces cravings and withdrawal, methadone which prevents withdrawal and blocks opioid effects, and naltrexone (brand: Vivitrol) which blocks opioid receptors entirely. Each has different mechanisms, benefits, and considerations.

MAT reduces opioid overdose deaths by 50% or more when combined with behavioral therapy. Patients on buprenorphine or methadone maintenance show 60-90% retention rates at 12 months compared to 10-20% for abstinence-only programs. The evidence is overwhelming and consistent across hundreds of studies.

Yes. Medicaid covers MAT in all 50 states. Most private insurance plans cover MAT medications and clinic visits under mental health parity. Our advisors can verify your specific coverage and help find a provider with availability.

As of January 2023, the X-waiver requirement was eliminated. Any DEA-registered provider with a standard Schedule III prescribing license can now prescribe buprenorphine for opioid use disorder, dramatically expanding access to MAT.

Find a MAT Provider Today

Our advisors can match you with a prescriber, verify your insurance, and check availability.

(855) 420-1911